Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novartis
Marketing
Novartis earns FDA ire for ‘misleading’ Fabhalta ad imagery
The FDA is not feeling the love in a commercial for Novartis’ paroxysmal nocturnal hemoglobinuria treatment Fabhalta.
Andrea Park
Sep 30, 2025 11:12am
Novartis, Boehringer debut DTC programs with reduced drug prices
Sep 29, 2025 12:06pm
AstraZeneca makes last-chance IRA appeal to US Supreme Court
Sep 25, 2025 11:08am
FDA targets Big Pharma in deluge of marketing letters
Sep 16, 2025 1:55pm
Novartis falls in another IRA price negotiation loss for pharma
Sep 12, 2025 10:41am
MS patient advocate Jamie-Lynn Sigler's advice to pharmas
Sep 9, 2025 2:59pm
